Meridian Bioscience Inc. (VIVO)


Stock Price Forecast

Jan. 31, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Meridian Bioscience Inc. chart...

About the Company

Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

CEO

John Kenny

Exchange

NASDAQ

Website

www.meridianbioscience.com

$333M

Total Revenue

704

Employees

$1B

Market Capitalization

37.70

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VIVO News

Meridian Bioscience

1mon ago, source: Lab Manager

Meridian Bioscience provides diagnostic test kits, purified reagents, and related products essential for the early identification and treatment of infectious diseases and other medical conditions.

Meridian Bioscience Stock Hits New 52-Week Low (VIVO)

12y ago, source: TheStreet.com

Shares are down 32% year to date as of the close of trading on Friday. Meridian Bioscience, Inc. operates as an integrated life science company. The company primarily engages in the development ...

Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO)

12y ago, source: TheStreet.com

Shares are down 20.2% year to date as of the close of trading on Tuesday. Meridian Bioscience, Inc., a life science company, engages in the development, manufacture, distribution, and sale of ...

Pulse Biosciences, Inc. (PLSE)

8h ago, source: Yahoo Finance

HAYWARD, Calif., April 24, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology ...

ASMB Assembly Biosciences, Inc.

6d ago, source: Seeking Alpha

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase ...

Why Invo BioScience Stock Is Soaring Today

19d ago, source: Hosted on MSN

INVO BioScience, Inc. (NASDAQ:INVO) shares are trading higher Wednesday after the company reported its fourth-quarter financial results after the market close Tuesday. Here's a look at the details.

Search Results

17h ago, source: The Business Journals

A Northern Kentucky nonprofit that provides critical funding for urban revitalization projects has received $250,000 to invest directly into urban revitalization projects.… As the workplace ...

Aadi Bioscience, Inc. Common Stock (AADI)

19h ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

PCRX Pacira BioSciences, Inc.

10d ago, source: Seeking Alpha

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in ...

Anixa Biosciences, Inc.

4mon ago, source: CNN

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following ...

Arcadia Biosciences Inc RKDA

5d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Genital Herpes Infection: Beyond a Clinical Diagnosis

3d ago, source: Medscape

Identified risk factors for acquiring genital herpes infection include larger number of lifetime sexual partners, history of sexually transmitted infections, increasing age, and sexually ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...